Lin Fen, Weng Miao-Shan, Wu Jiao-Ren, Fang Sen-Hai, Yang Li-Ye
Central Laboratory.
Clinical Laboratory, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou.
Blood Coagul Fibrinolysis. 2020 Mar;31(2):160-164. doi: 10.1097/MBC.0000000000000861.
: Coagulation factor XI (FXI) deficiency is a bleeding disorder with unpredictable severity. Patients with this condition usually suffer bleeding manifestations after trauma or surgery and are poorly correlated with plasma FXI activity (FXI:C). In the current study, we examined and identified the phenotype and genotype in four unrelated probands and their 32 relatives with hereditary FXI deficiency. The probands with severely reduced FXI:C but bleeding symptoms were only found in two probands. Mutation analysis showed that all the probands were FXI homozygous mutation or compound heterozygous mutation. Five mutations were identified including three nonsense mutations c.841C>T (p.Gln263X), c.1107C>A (p.Tyr351X) and c.1033A>T (p.Lys327X), respectively, one frameshift mutation c.1325delT (p.Leu424CysfsX8), and one splicing mutation c.326-1G>A. c.1033A>T (p. Lys327X), a novel mutation which lead to a premature stop codon at amino acid position 327, it may have an influence on protein characteristics and cause the corresponding disease.
凝血因子 XI(FXI)缺乏症是一种严重程度不可预测的出血性疾病。患有这种疾病的患者通常在创伤或手术后出现出血表现,且与血浆 FXI 活性(FXI:C)相关性较差。在本研究中,我们检查并鉴定了 4 名无亲缘关系的先证者及其 32 名患有遗传性 FXI 缺乏症的亲属的表型和基因型。FXI:C 严重降低但出血症状仅在两名先证者中发现。突变分析表明,所有先证者均为 FXI 纯合突变或复合杂合突变。共鉴定出 5 种突变,分别包括 3 种无义突变 c.841C>T(p.Gln263X)、c.1107C>A(p.Tyr351X)和 c.1033A>T(p.Lys327X),1 种移码突变 c.1325delT(p.Leu424CysfsX8),以及 1 种剪接突变 c.326-1G>A。c.1033A>T(p.Lys327X)是一种新突变,它导致在氨基酸位置 327 处出现提前终止密码子,可能会影响蛋白质特性并导致相应疾病。